Adducts to N-terminal valines in hemoglobin from butadiene metabolites

This publication has 15 references indexed in Scilit:

• ON THE MUTAGENIC ACTION OF ETHYLENE OXIDE AND DI-EPOXYBUTANE IN BARLEY
  Hereditas, 2010
• Epidemiological and mechanistic data suggest that 1, 3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace
  Carcinogenesis: Integrative Cancer Research, 1995
• On cancer risk estimation of urban air pollution
  Environmental Health Perspectives, 1994
• Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts
  Carcinogenesis: Integrative Cancer Research, 1994
• Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice
  Carcinogenesis: Integrative Cancer Research, 1992
• Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry (1943-1982).
  Environmental Health Perspectives, 1990
• Adducts of malonaldehyde and a few other aldehydes to hemoglobin
  Carcinogenesis: Integrative Cancer Research, 1989
• Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method
  Analytical Biochemistry, 1986
• The Nucleophilic Reactivity of Valine Methylamide. A Model of the N-Terminal Valine Residues of Hemoglobin.
  Acta Chemica Scandinavica, 1983
• Genetic toxicity of some important epoxides
  Mutation Research/Reviews in Genetic Toxicology, 1981